Verrica Pharmaceuticals

August 04, 2020

US FDA approval tracker: July

Go or no go? Pandemic looms over FDA timelines

Approval decisions are due for Jazz, Gilead and Galapagos in July, while Glaxo is preparing for a panel.

July 02, 2018

June rush drives near-record quarter for biotech flotations

Biotech IPOs raised a huge $2.3bn on Western exchanges in the second-quarter of 2018, as private companies rushed to market ahead of the summer lull.